Skip to main content
. Author manuscript; available in PMC: 2023 Apr 12.
Published in final edited form as: Schizophr Res. 2022 Aug 19;248:89–97. doi: 10.1016/j.schres.2022.07.019

Table 1.

Demographic and clinical information by group.

HC (n =
236)
CHR (n =
552)
CHR
CHR-NC (n
= 225)
CHR-C (n
= 73)
Age (years, mean ± SD)a 20.44 ± 4.72 19.21 ± 4.38 19.39 ± 4.59 18.49 ± 3.64
Sex, N (percentage)
 Female 111 (47.0) 236 (42.8) 104 (46.2) 27 (37.0)
 Male 125 (53.0) 316 (57.2) 121 (53.8) 46 (63.0)
Education (years, mean ± SD)b 12.8(3.6) 11.3(2.8) 11.3(2.7) 11.0(2.7)
Income bracket (mean ± SD) 4.1(1.7) 4.1(1.7) 4.1(1.6) 4.2(1.7)
SOPS (mean ± SD)
 Positive symptomsc 0.90 ± 1.50 11.42 ± 4.16 10.88 ± 4.41 13.19 ± 4.02
 Negative symptomsd 1.53 ± 2.47 11.49 ± 6.16 11.14 ± 6.30 12.27 ± 6.33
 Disorganizatione 0.65 ± 1.18 4.98 ± 3.06 4.70 ± 3.10 6.12 ± 3.97
 General symptomsf 1.31 ± 2.12 8.77 ± 4.35 7.99 ± 4.34 9.53 ± 4.33

HC = Healthy control subjects; CHR = Clinical High Risk subjects (at Baseline).

CHR-NC = Subjects who did not converted to psychosis by 2 years.

CHR-C = Subjects who converted to psychosis by 2 years; SOPS = Scale of Prodromal Symptoms.

a

HC > CHR (p < 0.001); HC > CHR_NC (p = 0.013); HC > CHR_C (p = 0.001).

b

HC > CHR (p < 0.001); HC > CHR_NC (p < 0.001); HC > CHR_C (p < 0.001).

c

HC < CHR (p < 0.001); HC < CHR_NC < CHR_C (p < 0.001).

d

HC < CHR (p < 0.001); HC < CHR_NC (p < 0.001); HC < CHR_C (p < 0.001).

e

HC < CHR (p < 0.001); HC < CHR_NC < CHR_C (p < 0.001).

f

HC < CHR (p < 0.001); HC < CHR_NC < CHR_C (p ≤ 0.001).